MorphoSys News

MorphoSys Gains After Novartis Discloses All Tender Offer Conditions Were Met

Seeking Alpha03:08

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading

European equities traded in the US as American depositary receipts were trending moderately lower late Thursday morning, declining 0.61% to 1,426.72 on the S&P Europe Select ADR Index. From continenta

MT NewswiresMay 16 23:04

Morgan Stanley Ups Stake in MorphoSys AG

TipRanksMay 16 22:58

Novartis Meets All Tender Offer Conditions to Acquire MorphoSys for EUR 68 Per Share in Cash

Novartis Meets All Tender Offer Conditions to Acquire MorphoSys for EUR 68 Per Share in Cash

Dow JonesMay 16 17:29

MorphoSys AG Reports Major Voting Rights Change

TipRanksMay 15 22:57

MorphoSys AG Reports Major Holdings Change

TipRanksMay 14 22:57

MorphoSys AG Announces Major Shareholding Change

TipRanksMay 13 22:57

MorphoSys (ETR:MOR) Shareholders Have Earned a 228% Return Over the Last Year

Yahoo FinanceMay 10 14:15

MorphoSys AG Announces Major Voting Rights Shift

TipRanksMay 8 23:27

MorphoSys AG Announces Major Voting Rights Changes

TipRanksMay 7 22:57

MorphoSys Announces Barclays PLC's Voting Rights Shift

TipRanksMay 3 23:27

MorphoSys AG Reports Shift in Major Holdings

TipRanksMay 2 23:27

Analysts' Opinions Are Mixed on These Technology Stocks: Morphosys (GB:0NDV), Thales (GB:0IW5) and Capgemini SE (GB:0HAZ)

TipRanksMay 1 17:13

European Equities Traded in the US as American Depositary Receipts Decline

European equities traded in the US as American depositary receipts fell Tuesday morning, down 0.5% to 1,373.3 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by food

MT NewswiresApr 30 23:11

Barclays PLC Acquires 10% Stake in MorphoSys AG

TipRanksApr 30 22:57

MorphoSys AG Navigates Takeover and Asset Sale

TipRanksApr 30 21:59

MorphoSys AG Set for Novartis Acquisition

TipRanksApr 30 05:00

MorphoSys Group AG Q1 2024 EPS €(9.27) Down From €(0.94) YoY; Revenue €27.5M Up From €24.3M YoY

MorphoSys Group AG Q1 2024 EPS €(9.27) Down From €(0.94) YoY; Revenue €27.5M Up From €24.3M YoY

BenzingaApr 30 04:14

MorphoSys AG: Due to Sale and Transfer of Tafasitamab, 2024 Fincl Guidance Published on Jan 30 Cannot Be Maintained and Therefore Was Revoked >MOR.FF

MorphoSys AG: Due to Sale and Transfer of Tafasitamab, 2024 Fincl Guidance Published on Jan 30 Cannot Be Maintained and Therefore Was Revoked >MOR.FF

Dow JonesApr 30 04:05

MorphoSys AG 1Q Rev EUR27.5M >MOR.FF

MorphoSys AG 1Q Rev EUR27.5M >MOR.FF

Dow JonesApr 30 04:03